Inclusion body myositis (IBM) is a muscle-wasting condition, which causes muscles to become thin and weak. It was recognised as a condition in its own right in the 1960s. It usually occurs in mid to later life and is more common in men than women.
Inclusion body myositis (IBM) is a muscle-wasting condition, which causes muscles to become thin and weak. It was recognised as a condition in its own right in the 1960s. It usually occurs in mid to later life and is more common in men than women.
Download your alert card
Alert cards are conveniently shaped to fit inside a wallet and outline key recommendations and precautions that a non-specialist clinician would need to know during a time of worsening health.
Exciting opportunity to join the Marketing & Communications team and be responsible for supporting the work of colleagues across the charity through delivering national, regional and trade media coverage.
Exciting opportunity to join the Marketing & Communications team and be responsible for supporting the work of colleagues across the charity through delivering national, regional and trade media coverage.
You will manage the charity’s bespoke 10K race event series, Town & Gown 10K, reporting to the Head of Events and Regional Development and working with an Events Assistant to achieve agreed event targets and objectives.
You will manage the charity’s bespoke 10K race event series, Town & Gown 10K, reporting to the Head of Events and Regional Development and working with an Events Assistant to achieve agreed event targets and objectives.
This is an exciting opportunity for the right candidate as we look to grow and develop relationships across an already successful region within Wales, West Midlands & South West.
This is an exciting opportunity for the right candidate as we look to grow and develop relationships across an already successful region within Wales, West Midlands & South West.
This is a great opportunity to lead Muscular Dystrophy UK’s policy and campaigning activity, focusing primarily on health policy and new treatment approval activities.
This is a great opportunity to lead Muscular Dystrophy UK’s policy and campaigning activity, focusing primarily on health policy and new treatment approval activities.
